Stage II Neuroendocrine Carcinoma of the Skin
2 clinical trials · Condition
◉ Watch Stage II Neuroendocrine Carcinoma of the Skin
| Record | Firm | Date |
|---|---|---|
| Oblimersen in Treating Patients With Merkel Cell Carcinoma (NCT00079131) | National Cancer Institute (NCI) | 2004-01-01 |
| S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer (NCT00068783) | National Cancer Institute (NCI) | 2003-10-01 |
Track Stage II Neuroendocrine Carcinoma of the Skin automatically
Every clearance here is in the API, with alerts when new ones post.